Profile
| Metric | Value |
|---|---|
| Full Name | Bruker Corporation |
| Ticker | NASDAQ: BRKR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | bruker.com |
| Employees | 11,396 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $48.11 | |
| Price, 1D Change | +2.12% | |
| Market Cap | $7B | |
| TTM Dividend Yield | 0.42% | |
| PE Ratio | - | |
| Beta | 1.14 | |
| Revenue | $3B | |
| Revenue, 1Y Change | +13.56% | |
| EPS | $0.76 | |
| EPS, 1Y Change | -73.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.05 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.76 | |
| EPS Estimate | $1.88 | |
| EPS Est. Change | +148.27% | |
| Revenue | $3.37B | |
| Revenue Estimate | $3.42B | |
| Revenue Est. Change | +1.50% | |
| Current Price | $48.11 | |
| Price Target | - | $55.00 |
| Price Tgt. Change | - | +14.32% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.55 | $2.90 | +13.81% | |
| $2.39 | $0.76 | -68.29% | |
| $1.88 | N/A | +148.27% | |
| $2.15 | N/A | +184.31% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.92B | $2.96B | +1.66% | |
| $3.35B | $3.37B | +0.42% | |
| $3.42B | N/A | +1.50% | |
| $3.47B | N/A | +3.20% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -18.19% | |
| Price, 3Y | -29.61% | |
| Market Cap, 1Y | -18.05% | |
| Market Cap, 3Y | -27.26% | |
| Revenue, 1Y | +13.56% | |
| Revenue, 3Y | +39.23% | |
| EPS, 1Y | -73.93% | |
| EPS, 3Y | -58.26% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $48.11 | |
| SMA 200 | $39.11 | |
| SMA 200 vs Price | -18.71% | |
| SMA 50 | $44.16 | |
| SMA 50 vs Price | -8.20% | |
| Beta | 1.14 | |
| ATR | $1.61 | |
| 14-Day RSI | 58.78 | |
| 10-Day Volatility | 36.12% | |
| 1-Year Volatility | 52.80% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.05 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.42% | |
| Total Dividend | $0.20 | |
| Dividends Paid | $30.20M | |
| Payout Ratio | 26.54% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $3.37B | |
| EPS | $0.76 | |
| Gross Profit | $1.66B | |
| Gross Margin | 49.34% | |
| Operating Profit | $379.80M | |
| Operating Margin | -39.37% | |
| Net Income | $113.80M | |
| Net Margin | 3.38% | |
| EBITDA | $563.60M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.26 | |
| Current Ratio | 1.60 | |
| Quick Ratio | 0.77 | |
| - | ||
| F-Score | 4 | |
| Altman Z-Score | 2.63 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 2.13 | |
| PB Ratio | 3.01 | |
| EV/EBITDA | 19.67 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.78B | |
| Cash & Equivalents | $183.40M | |
| Total Assets | $5.81B | |
| Current Assets | $2.05B | |
| Total Liabilities | $3.99B | |
| Current Liabilities | $1.28B | |
| Total Debt | $2.25B | |
| Short Term Debt | $64.60M | |
| Accounts Payable | $234.10M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $3.25B | |
| Operating Expenses | $1.28B | |
| Cost Of Goods Sold | $1.71B | |
| SG&A | $0.00 | |
| D&A | $183.80M | |
| Interest Expense | $0.00 | |
| Income Tax | $91.40M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $251.30M | |
| CFI | -$1.77B | |
| CFF | $1.24B | |
| Capex | $115.30M | |
| Free Cash Flow | $136.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| JP Morgan | → | |
| Barclays | → | |
| B of A Securities | → | |
| Wolfe Research | → | |
| Goldman Sachs | ||
| Rothschild & Co | ||
| Wells Fargo | → | |
| UBS | → | |
| TD Cowen | → |
Analyst sentiment
Institutional ownership
Screeners with BRKR
Data Sources & References
- BRKR Official Website www.bruker.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1109354/000119312525267049/0001193125-25-267049-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1109354/000095017025030897/0000950170-25-030897-index.htm
- BRKR Profile on Yahoo Finance finance.yahoo.com/quote/BRKR
- BRKR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/brkr
FAQ
What is the ticker symbol for Bruker Corporation?
The ticker symbol for Bruker Corporation is NASDAQ:BRKR
Does Bruker Corporation pay dividends?
Yes, Bruker Corporation pays dividends. The last payment was $0.05, with an ex-dividend date on December 8, 2025
What sector is Bruker Corporation in?
Bruker Corporation is in the Healthcare sector
What industry is Bruker Corporation in?
Bruker Corporation is in the Medical Devices industry
What country is Bruker Corporation based in?
Bruker Corporation is headquartered in United States
When did Bruker Corporation go public?
Bruker Corporation initial public offering (IPO) was on August 4, 2000
Is Bruker Corporation in the S&P 500?
No, Bruker Corporation is not included in the S&P 500 index
Is Bruker Corporation in the NASDAQ 100?
No, Bruker Corporation is not included in the NASDAQ 100 index
Is Bruker Corporation in the Dow Jones?
No, Bruker Corporation is not included in the Dow Jones index
When was Bruker Corporation last earnings report?
Bruker Corporation's most recent earnings report was on November 3, 2025
When does Bruker Corporation report earnings?
The next expected earnings date for Bruker Corporation is February 12, 2026